or
forgot password

    • cancer clinical trials in north carolina

    • Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer
    Rex Cancer Center at Rex Hospital

    Trial Locations
    Rex Cancer Center at Rex Hospital
    Cancer Centers of North Carolina - Raleigh
    Wilmed Radiation Oncology Services
    Forsyth Regional Cancer Center at Forsyth Medical Center
    Head and Neck Cancer
    Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission
    Presbyterian Cancer Center at Presbyterian Hospital

    Trial Locations
    Presbyterian Cancer Center at Presbyterian Hospital
    Duke Comprehensive Cancer Center
    Wake Forest University Comprehensive Cancer Center
    Leukemia
    Bevacizumab, Everolimus, and Erlotinib in Treating Patients With Advanced Solid Tumors
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Unspecified Adult Solid Tumor, Protocol Specific
    A Phase I Study of STA-5312 in Subjects With Advanced or Metastatic Solid Tumors
    Steven Limentani, MD
    Charlotte, North Carolina 28203
    Advanced or Metastatic Solid Tumors
    Biomarkers in Patients With Rectal Cancer Undergoing Chemotherapy and Radiation Therapy
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Colorectal Cancer
    Gemcitabine and/or Erlotinib as First-Line Therapy in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill

    Trial Locations
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Blumenthal Cancer Center at Carolinas Medical Center
    Batte Cancer Center at Northeast Medical Center
    Cape Fear Valley Medical Center Cancer Center
    Rex Cancer Center at Rex Hospital
    Lung Cancer
    Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer
    Presbyterian Cancer Center at Presbyterian Hospital

    Trial Locations
    Presbyterian Cancer Center at Presbyterian Hospital
    Duke Comprehensive Cancer Center
    CaroMont Cancer Center at Gaston Memorial Hospital
    Leo W. Jenkins Cancer Center at ECU Medical School
    High Point Regional Hospital
    New Hanover Radiation Oncology, PA
    Wake Forest University Comprehensive Cancer Center
    Forsyth Regional Cancer Center at Forsyth Medical Center
    Prostate Cancer
    Trial of Myocet in Metastatic Breast Cancer
    Brody School of Medicine @ ECU
    Greenville, North Carolina 27834
    Breast Cancer
    Ablatherm Integrated Imaging High Intensity Focused Ultrasound for the Indication of Low Risk, Localized Prostate Cancer
    University of North Carolina

    Trial Locations
    University of North Carolina
    Duke University Medical Center
    Prostate Cancer
    Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia
    Wake Forest University Comprehensive Cancer Center
    Winston-Salem, North Carolina 27157-1096
    Chronic Myeloproliferative Disorders, Kidney Cancer, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Multicenter Selective Lymphadenectomy Trial II (MSLT-II)
    Duke University Medical Center

    Trial Locations
    Duke University Medical Center
    Wake Forest University
    Melanoma
    Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor
    University of North Carolina

    Trial Locations
    University of North Carolina
    Duke University Medical Center
    Stage I Adrenocortical Carcinoma, Stage II Adrenocortical Carcinoma, Stage III Adrenocortical Carcinoma, Stage IV Adrenocortical Carcinoma
    ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill

    Trial Locations
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Blumenthal Cancer Center at Carolinas Medical Center
    Cervical Cancer
    Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
    Kinston Medical Specialists
    Kinston, North Carolina 28501
    Prostate Cancer
    Bortezomib After Combination Chemotherapy, Rituximab, and an Autologous Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill

    Trial Locations
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Wake Forest University Comprehensive Cancer Center
    Lymphoma
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Hope, A Women's Cancer Center

    Trial Locations
    Hope, A Women's Cancer Center
    Waverly Hematology Oncology
    University of North Carolina
    Carolinas Medical Center
    Presbyterian Hospital
    Carolinas Medical Center - Northeast
    Duke University Medical Center
    Moorehead Memorial Hospital
    Cape Fear Valley Health System
    Gaston Memorial Hospital
    Wayne Radiation Oncology
    Wayne Memorial Hospital
    Moses Cone Health System-Regional Cancer Center
    East Carolina University
    Maria Parham Hospital
    Park Ridge Hospital Breast Health Center
    High Point Regional Hospital
    Kinston Medical Specialists PA
    Southeastern Regional Medical Center
    Granville Medical Center
    FirstHealth of the Carolinas-Moore Regional Hosiptal
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer